Business Wire

MSCI Announces Strategic Alliance With Menai Financial Group

Share

MSCI Inc. (NYSE: MSCI), a leading provider of critical decision support tools and services for the global investment community, announced today its collaboration with Menai Financial Group (“Menai”), a leading provider of institutional-grade digital asset investment products and trading services. This strategic alliance marks one of MSCI’s first collaborations in the digital asset space. MSCI will aim to develop innovative tools for institutional investors seeking to capitalize on the growth of blockchain technology and digital assets.

The collaboration between MSCI and Menai comes at a time when institutional investors are increasingly considering opportunities within the digital asset class. As investor interest grows, MSCI has recognized the demand for robust frameworks and analytical tools to help provide insights into performance, risk and classification within this emerging asset class.

Menai’s expertise in digital assets will support MSCI’s development of the solutions institutional investors can leverage to navigate this market, understand the risks and challenges, and capitalize on emerging opportunities and developments as the rapidly growing industry drives technological change. This collaboration will aim to help institutional investors identify and understand the investment universe for digital assets and the relationship between digital assets and traditional assets.

Henry Fernandez, Chairman and CEO of MSCI, said: “Digital assets often get conflated with cryptocurrencies, but the market is far larger than that. Applications associated with digital assets are transforming long-established technologies such as payment, trading and settlement systems, among others. While investors are eager to enter the digital asset market as it matures, there is need for a robust suite of tools to gain reliable insight into the space.

“We are excited to fill that gap in collaboration with Menai and develop what is needed to power investment decisions in this evolving space. At MSCI, we are committed to capturing market disruptions—like digital assets—and helping our clients better understand their exposure to related trends as they construct portfolios with an eye towards forces shaping our future.”

Zoe Cruz, Founder and CEO of Menai Financial Group, said: “Institutional players are keen to participate in the digital asset markets, but have historically struggled to find the means to do so in a way that meets the high standards of professionalism, scale, risk management, security and rigor required by traditional financial markets. We are thrilled to see a sophisticated, norm-setting player like MSCI enter the digital asset space and are honoured that they have chosen Menai as one of their partners in this endeavour. We look forward to working together with MSCI as it provides institutional investors with transparent, secure and efficient solutions to help navigate the digital assets space.”

About MSCI Inc.

MSCI is a leading provider of critical decision support tools and services for the global investment community. With over 50 years of expertise in research, data, and technology, we power better investment decisions by enabling clients to understand and analyze key drivers of risk and return and confidently build more effective portfolios. We create industry-leading research-enhanced solutions that clients use to gain insight into and improve transparency across the investment process.

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements relate to future events or performance and involve risks that may cause actual results or performance differ materially and you should not place undue reliance on them. Risks that could affect results or performance are in MSCI’s Annual Report on Form 10-K for the most recent fiscal year ended on December 31 that is filed with the SEC. MSCI does not undertake to update any forward-looking statements. No information herein constitutes investment advice or should be relied on as such. MSCI grants no right or license to use its products or services without an appropriate license. MSCI MAKES NO EXPRESS OR IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE OR OTHERWISE WITH RESPECT TO THE INFORMATION HEREIN AND DISCLAIMS ALL LIABILITY TO THE MAXIMUM EXTENT PERMITTED BY LAW.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media Inquiries
PR@msci.com
Sam Wang +1 212 804 5244
Melanie Blanco +1 212 981 1049
Laura Hudson +44 (0) 207 336 9653

MSCI Global Client Services
EMEA Client Service + 44 20 7618.2222
Americas Client Service +1 888 588 4567 (toll free)
Asia Pacific Client Service + 852 2844 9333

About Business Wire

Business Wire
Business Wire



Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Exergen Sues Baxter International to Defend Its Right to Publish Data Regarding the Accuracy of Oral Thermometers24.4.2024 15:00:00 CEST | Press release

Last week Exergen Corporation filed a lawsuit against Baxter International Inc. in the United States District Court for the District of Massachusetts. As detailed in its complaint, Exergen’s lawsuit is a response to an effort by Baxter to censor true statements that Exergen has made in a scientific journal about a matter of public concern, among other issues. Through its lawsuit, Exergen seeks a legal declaration that its statements are not only true, but that they constitute First Amendment protected speech. Exergen looks forward to having this matter resolved in a court of law. Click here to read the formal complaint. About Exergen Corporation Exergen invented, manufactures, and markets two series of the TemporalScanner thermometer: a professional version for hospitals and clinics, and a consumer version sold in major retailers nationwide. More than three billion temperatures are taken each year with TemporalScanners. Used in thousands of hospitals and clinics across the country as w

‘World of Coffee & World Barista Championship Busan 2024’ to Launch on May 1st24.4.2024 15:00:00 CEST | Press release

Global coffee figures and baristas will gather at BEXCO, Busan in May. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240424527060/en/ World of Coffee & World Barista Championship Busan is held from May 1st to 4th at BEXCO, Busan. (Graphic: EXPORUM) Specialty coffee industry professionals from around the world will gather at BEXCO, Busan, from May 1-4, 2024, for the inaugural World of Coffee in Asia. This event will also feature the 2024 World Barista Championship, bringing together top baristas from across the globe. The Specialty Coffee Association (SCA) is working with host Busan Metropolitan City and organizer EXPORUM, with support of the 2024 Portrait Country, Indonesia, to debut World of Coffee in Busan, marking a significant milestone for the Asian coffee community. Over 20,000 global attendees, including 12,000 industry professionals from 70+ countries, are expected to visit BEXCO, anticipating contributions not only

Open Source Database Leader Percona Appoints Liz Warner to Chief Technology Officer24.4.2024 15:00:00 CEST | Press release

Percona, a leader in enterprise-grade, open source database software, support, and services, today announced the appointment of Liz Warner as its new Chief Technology Officer, to help meet the growing demand to make data simpler, faster, and easier to manage. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240424498483/en/ Liz Warner, Chief Technology Officer, Percona (Photo: Business Wire) An industry veteran, Warner comes to Percona with decades of technical and senior leadership experience; including a proven track record of driving successful organizational transformations. As CTO, she will play an instrumental role in the development and implementation of Percona’s ever-expanding collection of database solutions, including the much-anticipated Percona Everest, an open source cloud-native database platform. “We’ve reached a pivotal moment in open source, and Percona is doubling down on its commitment to staying open throu

The Antera Brand Back at the Summit of Light Alloy-wheel Producers24.4.2024 14:23:00 CEST | Press release

The Antera brand makes its comeback on the world stage during the 2024 Milan Design Week with a new collection of light alloy wheels. A premium made-in-Italy brand, Antera combines timeless design, cutting-edge technology, and the determination to overcome any obstacle. Its ambassador is the football champion Roberto Baggio, who, thanks to his successful career and winning mindset, is the perfect embodiment of the Italian’s brand spirit of 'No Compromise'. The new Antera advertising campaign’s slogan, "Where instinct meets genius, the myth becomes legend", attests to the dedication, courage, and vision of a brand which is able to project itself into the future. Antera was founded in Milan in 1991 and has produced some of the most iconic models in the field, including the Type 109, a three-spoke wheel that was named as “Alloy Wheel Design of the Year 1994”. G.M.P. Group, a company specialized in the global design and production of alloy wheels, is responsible for bringing it back to its

Parse Biosciences Launches Laboratory Automation Provider Program, Collaborates with Hamilton, Opentrons Labworks, SPT Labtech24.4.2024 14:15:00 CEST | Press release

Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced it has launched its Laboratory Automation Provider Program, enabling automation providers to readily support the adoption of Parse’s Evercode™ single cell products. By combining powerful automation with the Parse Evercode platform, customers will have unprecedented access to high-throughput single cell sequencing, enabling them to rapidly generate insights for large-scale studies. Parse’s Evercode single cell technology has enabled researchers to scale their projects to millions of cells or nuclei and has been widely adopted across oncology, immunology, neuroscience, basic research, and drug and target discovery. To facilitate scaling up these projects and to help researchers generate insights more quickly, Parse has developed automation-friendly workflows for high-throughput sample fixation, single cell barcoding, and library preparation. As key providers in the new Labor

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye